First real-world evidence for a menin inhibitor shows 77% ORR (10/13), 31% (4/13) CR/CRh, 75% (9/12) MRD negativity, and favorable tolerability ...
INDICATION AUCATZYL ® is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory B-cell precursor acute ...
Key points A 62-year-old man with hypertension and chronic renal disease presented to an emergency department with abdominal pain and chills. His vital signs were normal except for high blood pressure ...
In November, The Lancet published an international expert consensus review, "Contemporary, non-invasive imaging diagnosis of ...
KT-621 achieved deep STAT6 degradation across both the 100 mg and 200 mg dose groups tested, with median reductions of 94% and 98% in skin and blood, respectively, demonstrating strong translation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback